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ABSTRACT 
Combinatorial saturation mutagenesis -CSM- is a valuable tool for improving enzymatic 
properties from hot-spot residues discovered by directed enzyme evolution or 
performing semi-rational studies. 
CSM coupled to a reliable high-throughput screening assay -CV below 10 %- has been 
used to enhance turnover rates in the fungal laccase variant T2 from Myceliophthora 
thermophila. The influence of the highly conserved pentapeptide 509-513 on the redox 
potential of blue-copper containing enzymes is well described. We focused 
combinatorial saturation mutagenesis in residues Ser510 and Leu513. Libraries were 
constructed in Saccharomyces cerevisiae by in vivo overlap extension -IVOE- of the 
PCR products. This methodology provides a simple manner to build CSM libraries 
avoiding extra PCR reactions, by-products formation and in vitro ligation steps. After 
exploring more than 1,700 clones, mutant (7E1) with ∼3-fold better kinetics than 
parent type was found. 7E1 showed one synonymous mutation (L513L, CGT/TTG) and 
beneficial mutation S510G (TCG/GGG) which can not be achieved by conventional 
error-prone PCR techniques. Mutation S510G seems to affect the C-terminal plug, 
which modulates the transit of water and oxygen to the trinuclear copper cluster. 
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INTRODUCTION 
 
In the last decade, biocatalysis has undergone a spectacular renovation in the way of 
engineering enzymes towards biotechnological applications. To this end, laboratory 
enzyme evolution and semi-rational approaches have been successfully used as the 
main molecular tools to get biocatalysts more robust, stable, efficient and in general 
with many improved features 1-4. 
Mimicking the darwinist algorithm of natural selection, through several rounds of 
random mutagenesis and/or DNA recombination coupled to massive high-throughput 
screenings5, directed molecular evolution allows to tailor enzymes which can be applied 
from remediation to novel green processes6. In this evolutionary scenario, semi-
rational analysis -where researches are taking advantage from protein structural 
information to create and explore libraries constructed by saturation mutagenesis- 
constitutes also a powerful methodology7.  
Both Escherichia coli and Saccharomyces cerevisiae are the most successfully used 
host organisms for laboratory evolution experiments. Unlike the limited E. coli 
physiology -which posses a low DNA homologous recombination frequency-, S. 
cerevisiae eukaryotic machinery confers a broad array of possibilities for the 
construction of mutant libraries or for recombining –shuffling- DNA fragments8;9. 
Exchange of genetic material by recombination occurs in all living organisms and is the 
major contributor to high-quality diversity generation in the evolution of the species. In 
the particular case of S. cerevisiae the high frequency of homologous recombination 
encourages evolvers scientists  to use it as host to clone not only mutant libraries with 
linearized vectors, but also to try new in vivo alternatives to the standard in vitro 
protocols of generation of diversity10-12. Keeping this in mind, we are focusing part of 
our research in exploring and validating new high-throughput methods based on yeast 
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heterologous expression, which can successfully be employed to engineer enzymatic 
functions by forced evolution 12-15.  
Saturation random mutagenesis has long been used to investigate protein-DNA 
interactions and protein function. With this technique, one single amino acid codon is 
mutated to all other codons encoding the 20 naturally occurring amino acids. This 
method is used in directed evolution experiments to expand the number of amino acid 
substitutions accessible by random mutagenesis16. Furthermore, this technique can be 
employed to simultaneously mutagenize several codons -combinatorial saturation 
mutagenesis-, either in contiguous blocks or in separate positions, allowing the 
exploration of all possible combinations and permutations of interesting amino acid 
residues, in order to identify their optimal interactions and geometry for desirable 
protein or even create new functions or redesign active site for new substrates 17;18. 
Combinatorial saturation mutagenesis is typically carried out by laborious in vitro 
experiments based on the well-reported sequence overlap extension (SOE)19. Gene 
splicing by SOE recombines DNA sequences containing the mutated DNA fragments by 
several consecutives PCR reactions, which also requires an additional in vitro ligation 
step with the vector for cloning the whole fragment. Here, we are presenting a 
modification of the standard protocol of combinatorial saturation mutagenesis, using S. 
cerevisiae apparatus for recombining and splicing mutated libraries and at the same 
time creating a circular autonomously replicating vector, which can be easily coupled to 
high-throughput enzymatic schemes. To validate this protocol we have chosen as 
scaffold a laccase gene from the fungi Myceliophthora thermophila, which was 
previously evolved towards high expression levels in S. cerevisiae12.  Residues Ser510 
and Leu513 were targeted because of their relevance in the modulation of redox 
potential of this enzyme20. Libraries were constructed and explored by high-throughput 
methodology discovering a variant (7E1) which can provide new insights in the 
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parameters that are implicated in the modulation of the activity and redox potential of 
ascomycete laccases. 
 
EXPERIMENTAL PROCEDURES 
All chemicals were of reagent-grade purity. ABTS (2,2´-azino-bis(3-ethybenzthizoline-
6-sulfonic acid)) and S. cerevisiae transformation kit were purchased from Sigma-
Aldrich (Madrid, Spain). Parent laccase gene (MtLT2) was engineered as reported 
elsewhere12. E. coli XL2-blue competent cells and high-fidelity polymerase Pfu-Ultra 
were from Stratagene (La Jolla, CA). Protease deficient S. cerevisiae strain BJ5465 was 
from LGCPromochem (Barcelona, Spain). Shuttle vector pJRoC30 with auxotrophy for 
uracil and with ampicillin resistance gene was from Novozymes (Davis, CA). Zymoprep 
yeast plasmid miniprep kit, zymoclean gel DNA recovery kit, and DNA clean and 
concentrator TM-5 Kit were from Zymo Research (Orange, CA). QIAprep spin miniprep 
kit was from QIAGEN (West Sussex, UK). Restriction enzymes BamHI and XhoI were 
from New England Biolabs (Hertfordshire, UK). 
Culture media  
Minimal medium contained 100 ml 6.7% sterile yeast nitrogen base, 100 ml 19.2 g/L 
sterile yeast synthetic drop-out medium supplement without uracil, 100 ml sterile 20% 
raffinose, 700 ml sdd H2O, 1 ml 25 g/L chloramphenicol. YP medium contained 10 g 
yeast extract, 20 g peptone, and dd H2O to 650 ml. Expression medium contained 720 
ml YP, 67 ml 1M KH2PO4 pH 6.0 buffer, 10 μl 1M CuSO4, 111 ml 20% galactose, 1 ml 
25 g/L chloramphenicol and dd H2O to 1000 ml. YPAD solution contained 10 g yeast 
extract, 20 g peptone, 100 ml 20% sterile glucose, 100 mg adenine hemisulfate, 1 ml 
25 g/L chloramphenicol and dd H2O to 1000 ml. SC drop-out plates contained 6.7 g 
yeast nitrogen base, 100 ml 19.2 g/L sterile yeast synthetic drop-out medium 
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supplement without uracil, 20 g bacto agar, 100 ml 20% sterile glucose, 1 ml 25 g/L 
chloramphenicol, and dd H2O to 1000 ml.  
Production of MtLT2 in S. cerevisiae 
One single colony from S. cerevisiae clone containing MtLT2 parent-type or mutant 
laccase genes was picked from a SC drop-out plate, inoculated in 3 ml of minimal 
medium and incubated for 48 h at 30ºC and 225 rpm (Micromagmix shaker, Ovan, 
Spain). An aliquot of cells was removed and inoculated into a final volume of 50 ml of 
minimal medium (optical density, OD600=0.25) in a 500 ml flask. Incubation proceeded 
until two growth phases were completed (OD600=1.0; 6 to 8 h). Thereafter, 450 ml of 
expression medium containing 5.6mM CuSO4 were inoculated with the 50 ml preculture 
in a 2.0 -litter baffled flask (OD600=0.1). Incubation was stopped after 38-42 h at 30ºC 
and 225 rpm (laccase activity was maximal reaching a plateau; OD600=28-30). The 
cells were separated by centrifugation for 20 min at 3000 g (4ºC). Supernatant was 
double-filtered (by both glass membrane and a nitrocellulose membrane of 0.45 μm 
pore size) and concentrated to 20 ml in an ultrafiltration cell (Amicon/Millipore, 
Barcelona, Spain) equipped with a 10 kDa cutoff membrane.  
Purification of laccases 
Native and mutant laccases were purified using fast protein liquid chromatography 
(FPLC) equipment (LCC-500CI, Amersham Bioscience, Barcelona, Spain). Concentrated 
crude extract was first submitted to fractional precipitation with ammonium sulfate to 
50% saturation (w/v) at 0ºC and centrifuged at 17,000 g for 20 min. The supernatant 
was filtered and loaded into a hydrophobic interaction column (HIC, Hiload 16/10 
Phenyl Sepharose High Performance, Amersham Pharmacia) equilibrated with 1.8 M 
(NH4)2SO4 in 10 mM sodium phosphate buffer pH 6.1. Proteins were eluted with a 
linear gradient from 1.8 to 0 M (NH4)2SO4. Fractions with laccase activity were pooled, 
concentrated and dialyzed against 10 mM sodium phosphate buffer pH 6.1. Semi-
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purified laccase was applied to an anion exchange column (DEAE Sepharose CL-6B) 
preequilibrated with 10 mM sodium phosphate buffer pH 6.1. Proteins were eluted with 
a linear gradient from 0 to 0.4 M of NaCl. Fractions with laccase activity were pooled, 
concentrated and dialyzed against 10 mM sodium phosphate buffer pH 6.1. Fractions 
throughout the purification protocol were analyzed by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE). SDS-PAGE was performed with 8 % polyacrilamide using 
a Miniprotean 3 Cell (Biorad, US). Proteins were stained with both Coomassie brilliant 
blue and silver. Protein concentrations were determined by the method of Bradford21  
using the Bio-Rad protein reagent and bovine serum albumin as a standard. Purified 
laccases were stored at –20ºC. 
In vivo overlap extension (IVOE) for the construction of combinatorial 
saturation mutagenesis libraries. 
1.- PCR amplification 
Two separate PCR reactions (thermocycler Mycycler, Biorad, US) were simultaneously 
carried out to amplify the two DNA fragments which overlapped at specific positions 
corresponding to aminoacids 510 and 513 in MtLT2 sequence. PCR reactions were 
performed in a final volume of 50 μl contained 0.25 μM of each primer, 100 ng of 
template (MtLT2), dNTPs (0.25 mM each), 3% dimethyl sulfoxide (DMSO) and 2.5 
Units of Pfu-Ultra DNA polymerase. 
PCR 1 was done using the following oligonucleotides: RMLNsense (5’-
CCTCTATACTTTAACGTCAAGG-3’, binds at bp 5’-160-180-3’ of pJRoC30) and  
3CPOantisense (5´-GTAGACGACGCCSNNGCCGCCSNNGACGTGCCAGGCGAT-3´, binds 
at bp 5´-1859-1899- 3´ of MtLT2). Primers for PCR 2 were: 3CPOsense (5´-
ATCGCCTGGCACGTCNNSGGCGGCNNSGGCGTCGTCTACC-3´, binds at bp 5´-1859-
1899-3´ of MtLT2) and RMLCantisense (5’ GGGAGGGCGTGAATGTAAGC 3’, binds at bp 
5’-2139-2158-3’ of pJRoC30). Underlined and in bold are shown the codons submitted 
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to saturation mutagenesis, where N is (A+T+C+G) and S is (G+C). PCR conditions 
were as follows: 95ºC for 2 min (1 cycle), 94ºC for 0.45 min, 55ºC for 0.45 min, 74ºC 
for 2 min (28 cycles), and 74ºC for 10 min (1 cycle). PCR fragments where cleaned 
and concentrated (DNA clean and concentrator TM-5 Kit, Zymo Research), loaded into 
a low-melting-point preparative agarose, and purified using the Zymoclean gel DNA 
recovery kit (Zymo Research). 
2.- Plasmid linearization 
Plasmid pJRoC30 containing MtLT2 gene was linearized by cutting with restriction 
enzymes XhoI and BamHI (New England Biolabs, UK). Linearized vector (without 
parent gene) was cleaned, concentrated and purified as described above for PCR 
fragments. 
3.- In vivo overlap extension and cloning in Saccharomyces cerevisiae 
PCR fragments (200 ng each) were mixed with linearized vector (100 ng, ratio PCR-
product:vector 4:1) and transformed into competent yeast cells using the yeast 
transformation kit (Sigma, Madrid, Spain). Right before thermal shock, 10% DMSO was 
added in the transformation mixture to improve transformation efficiency (close to 
20,000 clones per transformation reaction). Transformed cells were plated in SC drop-
out plates and incubated for 2 days at 30ºC. Colonies containing the whole 
autonomously replicating vector were submitted to high-throughput screening (HTPS) 
assay. 
Coupling IVOE to HTPS assays: end-point colorimetric assay. 
Individual clones were picked into 96-well plates (Sero-well, Staffordshire, UK) 
containing 50 μl of minimal medium per well. In every single plate the column number 
6 was inoculated with standard (parent type, MtLT2), and 1 well (H1) was not 
inoculated (control). Plates were wrapped with parafilm (to prevent evaporation) and 
incubated at 30ºC and 225 rpm in a humidity shaker (Minitron-INFORS, Biogen, Spain). 
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After 48 h, 160 μl of expression medium were added to each well, and plates were 
again incubated. After 24 h, OD600 was recorded to determine the cell density in each 
well using a microplate reader (Versa Max, Molecular Devices, Sunnyvale, CA). 
Plates (master plates) were centrifuged (Eppendorf 5810R centrifuge, Germany) for 5 
min at 3000 g at 4ºC.  20 μl of supernatant were transferred from master plate (Liquid 
Handler Quadra96-320, Tomtec, Hamden, CT, US) to a replica plate. 180 μl of assay 
solution (final concentration in the well 3 mM ABTS, 100 mM acetate buffer pH 4.5)  
was added to each well of replica plate containing supernatant. Plates were stirred and 
the absorption at 418 nm (εABTS•+=36,000 M-1cm-1) was recorded in the plate reader. 
Plates were incubated at room temperature until green color was developed, and the 
absorption was measured again. Relative activities were calculated from the difference 
between initial absorption and that after the incubation divided by the OD600 of each 
well. Relative activities were normalized against the parent type in the corresponding 
plate. 
Rescreening procedures 
First rescreening: aliquots of 5 μl of the best clones were used from master plates to 
inoculate 50 μl of minimal media in new 96-well plates. Columns 1 and 12 (rows A and 
H) were not used to prevent the appearance of false positives. Five wells on the 
microplates were inoculated with the same clone. Five wells on each plate were used 
for the standard. The screening procedure then was the same as above, but including 
not only a endpoint assay but also a kinetic assay22. 
Second rescreening: an aliquot from the wells with the most active clones of first 
rescreening was inoculated in 3 ml of YPAD and incubated at 30ºC and 225 rpm for 24 
h. Plasmids from these cultures were extracted (Zymoprep yest plasmid miniprep kit, 
Zymo Research). As the product of the zymoprep was very impure and the 
concentration of extracted DNA was very low, the shuttle vectors were transformed 
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into super-competent E. coli cells (XL2-Blue, Stratagene) and plated onto LB-amp 
plates. Single colonies were picked and used to inoculate 5 ml LB-amp media and were 
grown overnight at 37 ºC and 225 rpm. Plasmids were then extracted (QIAprep spin 
miniprep kit, QIAGEN). S. cerevisiae was transformed with plasmids from the best 
mutants and also with parent type. Five colonies of every single mutant were picked 
and rescreened as described above (using both end-point and kinetic assays). 
DNA sequencing. 
 
Plasmid-containing variants laccase genes were sequenced at the Sequencing Core 
Facility of the Instituto de Investigaciones Biomedicas, CSIC, Madrid, using an Applied 
Biosystems 377 automated fluorescent DNA sequencer. The primers used were as 
follows: forward: RMLN and mtlsq2 (5´-GAAGGGCACCAACCTGC-3´, binds at bp 5´-
643-659-3´ of pJRoC30); reverse: mtlsq3 (5´-CGCACGTAAAAGTCGTGG-3´, binds at bp 
5´-1657-1673-3´of pJRoC30) and RMLC. 
Protein modeling 
We carried out a search in the Protein Data Bank for proteins of known structure 
homologous to MtLT2. The most similar protein to MtLT2, showing 75% identity in 
sequence, was a laccase from Melanocarpus albomyces 23 (PDB id: 1GW0). A structure-
based alignment of the sequences of both proteins was performed with 
GenTHREADER24. This alignment was used to obtain a model from the Swiss-Model 
protein modelling server (http://swissmodel.expasy.org/) which was analyzed with 
DeepView/Swiss-Pdb Viewer.25;26  
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RESULTS  
Construction of libraries by IVOE. 
IVOE methodology (Fig. 1) is based on the high frequency of homologous 
recombination of eukaryotic machinery to splice saturated mutagenized DNA fragments 
and at the same time use yeast gap repair mechanism in order to substitute in vitro 
ligation. First, two PCR reactions were carried out using degenerated primers to 
produce two PCR fragments which shared homologous sequences at the 3´and 5´ends 
respectively. These products already contained the saturated mutagenized codons, and 
were used directly by S. cerevisiae to in vivo shuffle each other through their 
recombination areas giving rise to a whole gene. Likewise, recombination not only 
spliced the two fragments in a complete gene but also shuffled the mutagenized 
codons. The whole mutagenized gene possessed big overhangs which recombined with 
the ends of the linearized vector forming an autonomously replicating plasmid. It is not 
straightforward to find out which event take place first (the splicing of the PCR 
fragments between themselves or their linkage to the linearized plasmid); in fact it is 
likely that even both phenomena happen simultaneously. With this approach, reliable 
high transformation frequency and short protocols for library expression can be 
derived, with a readily coupling to a HTPS assay. 
Library size and design of the recombination area: the size of the combinatorial 
saturation mutagenesis library is strictly depending on the genetic code, type of 
mutagenic codon and the number of sites chosen for mutagenesis27. In our case, two 
positions (510 and 513) were selected and submitted to combinatorial saturation 
mutagenesis using NNG/C randomization strategy instead of NNN randomization. 
NNG/C reduces the total number of variants, while all amino acids remain accessible 
and the complexity of the library can still be maintained. Positions 510 and 513 have a 
distance between them of only 6 bp, which enable them to recombine within one 
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primer. Degenerated primers were designed in such a manner that the mismatches lay 
on the middle of the primer. To get accurate annealing during PCR, 15 and 22 
nucleotides flanked the mismatches. Cloning efficiency did not change much if the 
homologous sequences were longer than 50 bp (data not shown; in our case the two 
PCR products to be in vivo recombined had as homology region 40 bp which comes 
from the own length of the degenerated primers). To recombine with linearized 
plasmid, overhangs design was ruled under the same principles, however if overhangs 
were smaller than 20 bp efficiency would be compromised.   
Library analysis 
A total of 1,740 clones from the library constructed by IVOE/combinatorial saturation 
mutagenesis at the codons for residues 510 and 513 were picked and screened for 
activity. Only 2.98 % showed improvements and 93.1 % displayed less than 10 % of 
the parent enzyme´s activity, MtLT2 (Fig. 2). The coefficient of variance (CV) of the 
end-point assay was found to be below 10 % (sensitivity limit of ABTS assay 5 nU/ml, 
Fig. 3). Figure 4 summarizes the HTPS used to explore the library constructed by IVOE. 
It is worth noting that the second rescreening using freshly transformed cells was 
necessary to discard false-positives, getting a correct comparison of the clones. This 
second rescreening was highly reliable since included mutants which were all in the 
same metabolic stage. After the 2 consecutives rescreens, only one mutant (7E1) was 
found to show significantly better kinetics than parent type. Variant 7E1 was purified to 
homogeneity and further characterized, displaying 3.1 fold better activity (Kcat 4440 
min-1 and 1420 min-1 for 7E1 and MtLT2, respectively). 7E1 variant was sequenced 
showing one synonymous mutation L513L (CTG/TTG) and one beneficial mutation 
S510G (TCG/GGG), which is responsible for the activity enhancement.  
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DISCUSSION 
SOE (sequence overlap extension) is a PCR-based method of recombining DNA 
sequences without reliance on restriction sites and of directly generating mutated DNA 
fragments in vitro. This method has been widely used to carry out the construction of 
libraries by combinatorial saturation mutagenesis27. Based on gene splicing, degenerate 
oligonucleotides are designed so that the ends of the resultant PCR products contain 
complementary sequences. Each primer pair is synthesized with a mismatched random 
nucleotide in the middle (such as –NNN-), flanked on both sides by nucleotides that 
specifically anneal to the target region. Therefore, first the DNA fragments must be 
amplified by two separate PCR reactions giving rise to 2 DNA fragments that overlap at 
a specific region. Afterwards, a third PCR reaction must be performed, where the two 
PCR products are mixed and their complementary sequences at their 3´ends anneal 
and then act as primers for each other. This step allows to reassemble a new version 
of the original full-length sequence, where the target codons are effectively 
randomized. Finally, the whole amplified and specifically/randomly mutagenized in 
one/several codon(s) must be in-vitro-ligated to a linearized vector to guarantee 
protein expression. 
Apart from the indispensable in vitro ligation, main bottlenecks of combinatorial 
saturation mutagenesis based on SOE stem from the consecutives PCR reactions which 
are associated with poor reaction yields and the formation of by-products. To 
overcome all these shortcomings we have developed an in vivo methodology which is 
faster, more efficient and non-mutagenic (the proofreading apparatus of the yeast cell 
prevents the appearance of additional mutations that are common with in vitro 
methods). In a simple and elegant experiment IVOE proceeds recombining PCR 
fragments, shuffling the mutagenized codons and repairing linearized vector with the 
help of specifically engineered overhangs. In SOE, an additional PCR reaction and the 
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in vitro ligation are fundamental requisites. IVOE saves those steps straightforwardly, 
just taking advantage of the eukaryotic machinery (since S. cerevisiae displays an 
exquisite frequency of homologous recombination). This technique was tuned using as 
parent type the laccase from Myceliophthora thermophila variant T2, (MtLT2) which is 
highly expressed in S. cerevisiae12. In spite of the fact that fungal laccases posses the 
highest redox potential –Eº- of this enzymatic group (close to +800 mV), their practical 
application in the oxidation of high Eº substrates and non-phenolic compounds (such 
as polycyclic aromatic hydrocarbons or in the pulp-kraft bleaching) are still under 
investigation28-35. Indeed, over the years, the broad range in the fungal laccases Eº 
(from +465 mV of Myceliophthora thermophila laccase –MtL-, to +790 mV of Trametes 
–Polyporus or Coriolus- versicolor laccase) has been subject of study trying to figure 
out which parameters are behind the differences in the Eº20;36-38. It is well known that 
a hydrophobic residue (either Phe or Leu) at the axial position of the T1 Cu site is 
implicated in the elevated Eº of fungal laccases39. However, there are broad 
differences even amongst the fungal laccases –see table 1-; thus it is clear that the 
non-coordinating Leu or Phe residue at the T1 site cannot be the sole contributor to 
this effect40. In this sense, it has been described the significance of a pentapeptide 
509-513 segment highly conserved located near the Cu T1, which also contains the 
mentioned axial ligand of the T1 site at position 51320. In MtLT2, Ser510 forms part of 
the tripeptide VSG which is common to the low redox potential laccases. Unlike VSG, 
the tripeptide LEA appears in high redox potential laccases. VSG/LEA tripeptide is 
located in the vicinity of substrate binding and the T1 Cu.  Because of their relevance 
and their proximity in their sequence space (just 6 bp of distance in between), we 
decided to study residues 510 and axial ligand at 513 by IVOE. As expected, the 
activity landscape displayed a large fraction of the library losing performance (i.e. the 
region was quite sensitive to amino acid replacement, Fig. 2). Variant 7E1 was the only 
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positive mutant with significant improvements vs parent type, showing only one amino 
acid change in position 510 and one synonymous mutation at position 513. It is worth 
noting that although other positives variants were sequenced none displayed changes 
at position 513. To our knowledge, this is the first time that the position corresponding 
to the axial ligand is submitted to saturation mutagenesis. Previously Xu and 
coworkers20;38 replaced the axial ligand by site-directed mutagenesis without improving 
the enzymological features of fungal laccases. In a recent work the axial ligand of the 
T1 site was site-mutated in the bacterial laccase CotA from Bacillus subtilis and, 
although redox potential was enhanced, the modification affected negatively the 
thermodynamic stability of the enzyme41. According to our experimental data, axial 
ligand of the T1 site in MtLT2 behaves as a strictly conserved amino acid (or in other 
words, has already achieved the highest level of fitness or evolution) and any change 
by another residue would not give a significant increase in the activity of the 
biocatalyst. On the other hand, S510G was the only mutation that conferred better 
performance to variant 7E1. Interestingly, substitution S510G of 7E1 can not be 
achieved from a single base substitution (i.e. by random mutagenesis experiment, see 
table 2). Taking into account that mutation rates must be low for whole-gene evolution 
and that error-prone PCR methodologies are limited to single point mutation and 
specific bias, a large fraction of protein sequence space would remain still unexplored 
(in fact, with single base mutation, only 5.7 amino acid substitutions on average are 
accessible from any given amino acid residue). Unlike error-prone PCR, IVOE enabled 
us to access to the overall array of possibilities at the targeted residues giving us a 
whole picture about the interactions, incompatibilities and synergy of studied positions.  
We used the structure of Melanocarpus albomyces laccase23 (75 % of sequence 
identity to MtLT2) to build a model for 7E1. In parent type Ser510 was connected with 
the terminal Asp556 through a hydrogen bond (Fig. 5). Asp556 is part of the C-
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terminal plug, a structure highly conserved in ascomycete laccases42. This plug is 
supposed to be involved in modulating redox potential of these enzymes regulating 
both the entrance and exit of oxygen and water from the active pocket through a 
broad tunnel. In variant 7E1 the interaction between Ser510 and Asp556 no longer 
exists, which may have a double effect: 
i) the removal of lateral chain of Ser510 enhances the tunnel which leads to 
the trinuclear copper cluster (Fig. 6). 
ii) After breaking the hydrogen bond between Ser510 and Asp556 the grade of 
tightness is lowered. 
Our research is currently focused in the electrochemical characterization of 7E1 and in 
the use of this variant as parent type for further studies of combinatorial saturation 
mutagenesis of the C-terminal plug by IVOE. 
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LEGENDS 
Fig.1. In vivo overlap extensión –IVOE- strategy for combinatorial saturation 
mutagenesis. N-terminal overhang was created in PCR 1 generating 35 bp of homology 
to the BamHI end site of linearized vector. C-terminal overhang was created in PCR 2 
generating 62 bp of homology to the XhoI end site of linearized vector. Combinatorial 
saturation mutagenesis at amino acid positions 510 and 513 was carried out using a 
set of degenerate synthetic oligonucleotides (NNG/C for each targeted residue) with 22 
bp and 15 bp flanking mutation sites. 
 
Fig.2. Activity landscape of library constructed by IVOE. Activities of clones are plotted 
in descending order. The library size for two mutated sites was calculated by a 
binomial probability approximation27. Solid horizontal line shows the activity of the 
parent (MtLT2) in the assay. Dashed lines indicate the coefficient of variation of the 
assay.  
 
Fig.3. Validation of the screening method with a plate of 96 parent type samples. 
Enzymes activities are plotted versus well position (columns) and in descending order 
(circles). The CV for this screen was 9.0 %. 
 
Fig.4. High-throughput screening methodology. 
 
Fig. 5. Local interactions in position 510. 
 
Fig. 6. Relative position of Ser510 (yellow) and Asp556 (red). In variant 7E1 it is 
apparent the enhancement of the tunnel which leads to the trinuclear copper cluster. 
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Table 1. Eº of several blue multicopper enzymes28. 
 
Species Organism Enzyme 
CuT1 
Eº(V) 
Potential 
axial 
ligand  
Trametes 
versicolor 
Basidiomycete Laccase +0.79 Phe 
Trametes 
villosa 
Basidiomycete Laccase +0.79 Phe 
Neurospora 
crassa 
Ascomycete Laccase +0.78 Leu 
Rhizoctonia 
solani 
Deuteromycete Laccase +0.71 Leu 
Coprinus 
cinereus 
Basidiomycete Laccase +0.55 Leu 
Scytalidium 
thermophilum 
Basidiomycete Laccase +0.51 Leu 
Homo sapiens Mammalian Ceruloplasmin +0.49 Met 
Myrothecium 
verrucaria 
Fungi 
mitosporic 
Bilirubin 
oxidase 
+0.48 Met 
Myceliophthora 
thermophila 
Ascomycete Laccase +0.47 Leu 
Rhus vernicifera Plant Laccase +0.43 Met 
Zucchini 
(Cuburbita 
pepo) 
Plant 
Ascorbate 
oxidase 
+0.34 Met 
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Table 2. Comparison between mutation achieved by IVOE at position 510 and 
accessible mutations by conventional error-prone PCR. 
 
 
 
BENEFICIAL MUTATION ACCESIBLE AMINO ACID BY SINGLE BASE 
SUBSTITUTION 
S510G (TCG8.6/GGG6.0) L(TTG27.2), P(CCG5.3), T(ACG8.0), A(GCG6.2), 
W(TGG10.4) 
 
 
*Subscript numbers indicate codon usage in S. cerevisiae.  
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IVOE STRATEGY FOR COMBINATORIAL SATURATION MUTAGENESIS
IN VIVO RECOMBINATION
IN YEAST 
Linearized vector 
PCR fragment 1
PCR fragment 2
3´5´
NNG/C
Ser510 
NNG/C
Leu513 
5´3´
5´ 3´ 
3´ 5´
NNG/C
Ser510 
NNG/C
Leu513 
PCR1 PCR2
Repaired 
replicating 
 vector 
overhang 
overhang 
Fig.1
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 SCREENING ASSAY 
(ABTS) 
Fig.4
- -
-
MASTER PLATE Centrifugation and 
transfer 
of 20 μl of 
supernatant 
-First rescreen: (five wells per clone). 
-Second rescreen: yeast plasmid extraction, 
E. coli transformation, bacterial plasmid extraction, 
yeast transformation. 
  
Incubation for 48 h in minimal 
media at 30ºC and 225 rpm. 
Addition of expression media  
and further incubation for 24 h. 
 
Colony transfer 
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Parent type MtLT2 7E1 variant
Fig.5 
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Parent type MtLT2 7E1 variant
Fig.6 
